Latest filing published 15 Nov 2021 for MARRONE BIO INNOVATIONS INC, €404k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Ardsley Advisory Partners LP: trading record in brief
Ardsley Advisory Partners LP has filed trades across 2 companies (mainly through SEC (Form 4)), most often in SunOpta Inc. and Marrone Bio Innovations Inc. Over a trading history stretching from 5 September 2019 to 11 November 2021, the count stands at 29 filings.
Market trades split into 14 purchases (€335k) and 6 sales (€17.2M). Sales outweigh purchases by €16.9M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants and 5 option exercises.
A typical purchase (the median) is worth €12k. On 1 out of 12 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The latest filing, published on 15 November 2021, reports a share grant of €404k in Marrone Bio Innovations Inc. The clock since the last published purchase (20 December 2019) now reads 2,516 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ardsley Advisory Partners LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 618,014 shares@ US$0.75100.0% of flowCommon StockSEC:0001019056-21-000595:0
- 50,000 shares@ US$1.26Common StockSEC:0001019056-21-000004:0
- 50,000 shares@ US$1.26Common StockSEC:0001019056-21-000004:1
- 1,648,037 shares@ US$0.7545.7% of flowCommon StockSEC:0001019056-20-000634:0
- 343,341 sharesCommon StockSEC:0001019056-20-000501:0
- 2,300,000 shares@ US$6.0066.3% of flowCommon StockSEC:0001019056-20-000487:0
- 1,000,000 shares@ US$6.0028.8% of flowCommon StockSEC:0001019056-20-000487:1
- 25,000 shares@ US$6.560.8% of flowCommon StockSEC:0001019056-20-000465:0
- 25,000 shares@ US$7.100.9% of flowCommon StockSEC:0001019056-20-000465:1
- 50,000 shares@ US$6.311.5% of flowCommon StockSEC:0001019056-20-000465:2
- 12,500 shares@ US$6.770.4% of flowCommon StockSEC:0001019056-20-000465:3
- 429,176 sharesCommon StockSEC:0001019056-20-000295:0
- 874,314 shares@ US$1.0018.6% of flowCommon StockSEC:0001019056-20-000204:0
- 874,326 shares@ US$1.0018.1% of flowCommon StockSEC:0001019056-19-000679:0
- 22,300 shares@ US$2.42990.3% of flowCommon StockSEC:0001019056-19-000677:0Canonical exit: 18 Mar 2020 (T+90)
- 25,000 shares@ US$2.42990.3% of flowCommon StockSEC:0001019056-19-000677:1Canonical exit: 18 Mar 2020 (T+90)
- 25,000 shares@ US$2.300.3% of flowCommon StockSEC:0001019056-19-000638:0Canonical exit: 6 Feb 2020 (T+90)
- 25,000 shares@ US$2.00060.3% of flowCommon StockSEC:0001019056-19-000624:0Canonical exit: 3 Feb 2020 (T+90)
- 25,000 shares@ US$1.750.2% of flowCommon StockSEC:0001019056-19-000578:0Canonical exit: 26 Jan 2020 (T+90)
- 25,000 shares@ US$1.69940.2% of flowCommon StockSEC:0001019056-19-000578:1Canonical exit: 27 Jan 2020 (T+90)
- 7,900 shares@ US$1.74670.1% of flowCommon StockSEC:0001019056-19-000567:0Canonical exit: 22 Jan 2020 (T+90)
- 2,700 shares@ US$1.69960.0% of flowCommon StockSEC:0001019056-19-000567:1Canonical exit: 22 Jan 2020 (T+90)
- 5,000 shares@ US$1.52760.0% of flowCommon StockSEC:0001019056-19-000564:0Canonical exit: 20 Jan 2020 (T+90)
- 7,670 shares@ US$1.66330.1% of flowCommon StockSEC:0001019056-19-000564:1Canonical exit: 21 Jan 2020 (T+90)
- 1,500 shares@ US$1.600.0% of flowCommon StockSEC:0001019056-19-000564:2Canonical exit: 21 Jan 2020 (T+90)
25 of 27 declarations
